MSA
MCID: MLT021
MIFTS: 70

Multiple System Atrophy (MSA) malady

Genetic diseases, Rare diseases, Neuronal diseases categories
Download this MalaCard

Summaries for Multiple System Atrophy

About this section
Sources:
21Genetics Home Reference, 43NIH Rare Diseases, 44NINDS, 65Wikipedia, 47OMIM, 33MalaCards
See all sources

Fully expand this MalaCard
NIH Rare Diseases:43 Multiple system atrophy (msa) is a progressive neurodegenerative disorder characterized by symptoms of autonomic nervous system failure such as fainting spells and bladder control problems, combined with motor control symptoms such as tremor, rigidity, and loss of muscle coordination.  msa affects both men and women primarily in their 50s.  the disease tends to advance rapidly over the course of 9 to 10 years, with progressive loss of motor skills, eventual confinement to bed, and death. the cause of multiple system atrophy is unknown, although environmental toxins, trauma, and genetic factors have been suggested. there is no cure for this condition, and there is no known way to prevent the disease from getting worse. the goal of treatment is to control symptoms.  last updated: 10/7/2010

MalaCards: Multiple System Atrophy, also known as shy-drager syndrome, is related to progressive supranuclear palsy and parkinson's disease. An important gene associated with Multiple System Atrophy is COQ2 (coenzyme Q2 4-hydroxybenzoate polyprenyltransferase), and among its related pathways are Parkinsons Disease Pathway and Alpha-synuclein signaling. The compounds thioflavine s and methionine sulfoxide have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and bone, and related mouse phenotypes are taste/olfaction and integument.

Genetics Home Reference:21 Multiple system atrophy is a progressive brain disorder that affects movement and balance and disrupts the function of the autonomic nervous system. The autonomic nervous system controls body functions that are mostly involuntary, such as regulation of blood pressure.

NINDS:44 Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by symptoms of autonomic nervous system failure such as fainting spells and bladder control problems, combined with motor control symptoms such as tremor, rigidity, and loss of muscle coordination. MSA affects both men and women primarily in their 50s.

Wikipedia:65 Multiple-system atrophy (MSA) is a degenerativeneurological disorder. MSA is associated with the... more...

Description from OMIM:47 146500

Aliases & Classifications for Multiple System Atrophy

About this section
Sources:
8Disease Ontology, 43NIH Rare Diseases, 21Genetics Home Reference, 44NINDS, 47OMIM, 10DISEASES, 45Novoseek, 49Orphanet, 31LifeMap Discovery™, 62UMLS, 35MeSH, 58SNOMED-CT, 40NCIt, 36MESH via Orphanet, 26ICD10 via Orphanet, 59SNOMED-CT via Orphanet, 63UMLS via Orphanet
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases, Rare diseases
Anatomical: Neuronal diseases


Characteristics (Orphanet epidemiological data):

49
multiple system atrophy:
Inheritance: Multigenic/multifactorial,Sporadic; Prevalence: 1-9/100000; Age of onset: Adulthood


Aliases & Descriptions:

multiple system atrophy 8 43 21 44 47 10 45 49 31 62
shy-drager syndrome 8 21 44 62
msa 43 21 49
striatonigral degeneration 21 62
multisystem atrophy 49
opca 21


External Ids:

Disease Ontology8 DOID:4752
MeSH35 D012791
NCIt40 C85066
OMIM47 146500
SNOMED-CT58 230297002, 16576004
MESH via Orphanet36 D019578
ICD10 via Orphanet26 G90.3
SNOMED-CT via Orphanet59 230297002
UMLS via Orphanet63 C0393571

Related Diseases for Multiple System Atrophy

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Multiple System Atrophy via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 122)
idRelated DiseaseScoreTop Affiliating Genes
1progressive supranuclear palsy31.4SLC6A3
2parkinson's disease31.4SNCA, SNCB, RPS27A, DRD2, SLC6A3
3striatonigral degeneration30.7SNCA, RPS27A, DRD2, SLC6A3
4spinocerebellar ataxia30.6FMR1, RPS27A, SNCA
5dementia30.6SQSTM1, CRYAB, SLC6A3, FMR1, RPS27A, SNCB
6lewy body dementia30.5SNCA, SNCB
7rem sleep behavior disorder30.3SLC6A3, SNCA
8essential tremor30.3SLC6A3, FMR1, SNCA
9motor neuron disease30.3SNCA, RPS27A, SQSTM1
10huntington's disease30.2DRD2, CHAT
11alzheimer's disease30.1CHAT, SNCA, SNCB, RPS27A, SQSTM1, CRYAB
12tauopathy30.1RPS27A, SNCA
13myositis30.0RPS27A, SNCA
14myotonic dystrophy30.0CRYAB, FMR1
15amyotrophic lateral sclerosis30.0CHAT, SNCA, RPS27A, SQSTM1, CRYAB, SLC6A3
16pick's disease29.9CHAT, SNCA, RPS27A, SQSTM1, CRYAB
17breast cancer29.7DRD2, CRYAB, SQSTM1, RPS27A, SNCA
18pure autonomic failure10.7
19neuronitis10.7
20striatonigral degeneration infantile10.6
21ataxia10.6
22olivopontocerebellar atrophy10.6
23cerebritis10.5
24multiple system atrophy with orthostatic hypotension10.5
25autonomic dysfunction10.5
26sporadic infantile bilateral striatal necrosis10.4
27corticobasal degeneration10.4
28dysautonomia10.4
29cerebellar ataxia10.4
30sleep disorder10.4
31tremor10.4
32multiple system atrophy, cerebellar type10.4
33cerebellar degeneration10.3
34torsion dystonia10.3
35neuroleptic malignant syndrome10.3
36machado-joseph disease10.2
37apraxia10.2
38dystonia10.2
39respiratory failure10.2
40multiple system atrophy, parkinsonian type10.2
41muscular atrophy10.2
42spinal muscular atrophy10.2
43spinocerebellar ataxia type 710.2
44mitochondrial infantile bilateral striatal necrosis10.2
45lateral sclerosis10.2
46blepharospasm10.2
47cervicitis10.2
48laryngitis10.2
49retinitis10.2
50cerebral atrophy10.2

Graphical network of the top 20 diseases related to Multiple System Atrophy:



Diseases related to multiple system atrophy

Symptoms for Multiple System Atrophy

About this section
Sources:
47OMIM
See all sources

Symptoms by clinical synopsis from OMIM:

146500

Clinical features from OMIM:

146500

Drugs & Therapeutics for Multiple System Atrophy

About this section
Sources:
42NIH Clinical Center, 6ClinicalTrials, 31LifeMap Discovery™, 62UMLS, 41NDF-RT
See all sources

Drug clinical trials:

Search ClinicalTrials for Multiple System Atrophy

Search NIH Clinical Center for Multiple System Atrophy

Cell-based therapeutics:


LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine
Read about Multiple System Atrophy cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Multiple System Atrophy:
Mesenchymal stem cells for multiple system atrophy
Embryonic/Adult Cultured Cells Related to Multiple System Atrophy:
Bone marrow-derived mesenchymal stem cells, PMID: 19513327

Genetic Tests for Multiple System Atrophy

About this section

Anatomical Context for Multiple System Atrophy

About this section
Sources:
31LifeMap Discovery™, 33MalaCards
See all sources

MalaCards organs/tissues related to Multiple System Atrophy:

33
Brain, Testes, Bone, Eye, Skin, Bone marrow, Heart, Cortex, Subthalamic nucleus, Olfactory bulb, Temporal lobe, Cerebellum, Colon, Skeletal muscle, Whole blood, Pons

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Cells/anatomical compartments in embryo or adult related to Multiple System Atrophy:
id TissueAnatomical CompartmentCell Relevance
1 LimbPelvic GirdleBone Marrow Stromal Cells Potential therapeutic candidate
2 BoneBone MarrowBone Marrow Stromal Cells Potential therapeutic candidate
3 PlacentaChorionic VillusChorionic Mesenchymal Stromal Cells Potential therapeutic candidate

Animal Models for Multiple System Atrophy or affiliated genes

About this section
Sources:
37MGI
See all sources

MGI Mouse Phenotypes related to Multiple System Atrophy:

37
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053948.9SLC6A3, DRD2, SNCA
2MP:00107717.7SNCA, FMR1, SQSTM1, DRD2, SLC6A3
3MP:00053897.6CHAT, SNCA, FMR1, DRD2, SLC6A3
4MP:00053907.4CHAT, SNCA, SQSTM1, CRYAB, DRD2, SLC6A3
5MP:00053767.3SLC6A3, DRD2, SQSTM1, SNCB, SNCA, CHAT
6MP:00053867.0CHAT, SNCA, FMR1, SQSTM1, CRYAB, DRD2
7MP:00107686.9CHAT, SNCA, SNCB, SQSTM1, CRYAB, DRD2
8MP:00036316.7SLC6A3, CHAT, SNCA, SNCB, FMR1, SQSTM1
9MP:00053786.7CHAT, SNCA, SNCB, FMR1, SQSTM1, CRYAB

Publications for Multiple System Atrophy

About this section
Sources:
52PubMed
See all sources

Articles related to Multiple System Atrophy:

(show top 50)    (show all 665)
idTitleAuthorsYear
1
Update on novel familial forms of Parkinson's disease and multiple system atrophy. (24262183)
2014
2
XIAP immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy. (23993308)
2014
3
The basal ganglia in perceptual timing: Timing performance in Multiple System Atrophy and Huntington's disease. (24135486)
2014
4
Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy. (24243499)
2013
5
Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. (22806758)
2012
6
The neuropathology, pathophysiology and genetics of multiple system atrophy. (22074330)
2012
7
"Hot cross bun" sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging. (22209432)
2012
8
Non-gaussianity of low frequency heart rate variability and sympathetic activation: lack of increases in multiple system atrophy and Parkinson disease. (22371705)
2012
9
Post mortem cerebrospinal fluid I+-synuclein levels are raised in multiple system atrophy and distinguish this from the other I+-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. (21856424)
2012
10
Serum urate levels are not associated with survival in multiple system atrophy. (21354851)
2011
11
Uric acid as a potential disease modifier in patients with multiple system atrophy. (21542015)
2011
12
Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. (21962800)
2011
13
Genetic players in multiple system atrophy: unfolding the nature of the beast. (21601954)
2011
14
Nonmotor presentations of multiple system atrophy. (21343894)
2011
15
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. (20176003)
2010
16
Role of TPPP/p25 on I+-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy. (20849899)
2010
17
Multiple-system atrophy presenting with low rectal compliance and bowel pain. (20629156)
2010
18
Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging. (20395701)
2010
19
White matter hyperintensities in patients with multiple system atrophy. (19468782)
2009
20
MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. (19514077)
2009
21
Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. (19429902)
2009
22
A validation exercise on the new consensus criteria for multiple system atrophy. (19845011)
2009
23
Multiple system atrophy: a primary oligodendrogliopathy. (18825660)
2008
24
Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. (18178568)
2008
25
Loss of A5 noradrenergic neurons in multiple system atrophy. (18297292)
2008
26
PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease. (18236005)
2008
27
Multiple system atrophy: alpha-synuclein and neuronal degeneration. (18018485)
2007
28
Altered venous capacitance as a cause of postprandial hypotension in multiple system atrophy. (17139443)
2007
29
Abnormal temporal discrimination threshold in patients with multiple system atrophy. (17260339)
2007
30
Paradoxical vocal cord motion: a review focused on multiple system atrophy. (17482397)
2007
31
Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy. (17235127)
2007
32
Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy. (17544807)
2007
33
Bilateral striopallidodentate calcification (Fahr's syndrome) and multiple system atrophy in a patient with longstanding hypoparathyroidism. (18018479)
2007
34
Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. (17291816)
2007
35
Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy. (17485650)
2007
36
Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy. (17562934)
2007
37
Moxibustion, an alternative therapy, ameliorated disturbed circadian rhythm of plasma arginine vasopressin and urine output in multiple system atrophy. (17603243)
2007
38
Camptocormia associated with focal myositis in multiple-system atrophy. (16211611)
2006
39
Hyperintensity of the middle cerebellar peduncles on fluid-attenuated inversion recovery imaging: variation with age and implications for the diagnosis of multiple system atrophy. (17110685)
2006
40
CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. (16894110)
2006
41
Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy). (15583958)
2005
42
Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. (15035294)
2004
43
Involvement of medullary serotonergic groups in multiple system atrophy. (14991820)
2004
44
Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). (12764627)
2003
45
Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy. (14639688)
2003
46
The pathogenesis of multiple system atrophy: past, present, and future. (11009180)
2000
47
Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. (9452329)
1998
48
Olivopontocerebellar atrophy and multiple system atrophy: clinical follow-up of 10 patients studied with PET. (9667610)
1998
49
A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. (7876880)
1995
50
Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients. (8410065)
1993

Variations for Multiple System Atrophy

About this section
Sources:
64UniProtKB/Swiss-Prot
See all sources

UniProtKB/Swiss-Prot genetic disease variations for Multiple System Atrophy:

64 (show all 11)
id Symbol AA change Variation ID SNP ID
1COQ2p.Phe29LeuVAR_070239
2COQ2p.Pro49HisVAR_070240
3COQ2p.Ser57ThrVAR_070241
4COQ2p.Met78ValVAR_070243
5COQ2p.Ile97ThrVAR_070244
6COQ2p.Pro107SerVAR_070245
7COQ2p.Ser113PheVAR_070246
8COQ2p.Thr267AlaVAR_070247
9COQ2p.Ser297CysVAR_070248
10COQ2p.Arg337GlnVAR_070250
11COQ2p.Val343AlaVAR_070251

Expression for genes affiliated with Multiple System Atrophy

About this section
Sources:
2BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Multiple System Atrophy

Search GEO for disease gene expression data for Multiple System Atrophy.

Pathways for genes affiliated with Multiple System Atrophy

About this section
Sources:
50PathCards, 38NCBI BioSystems Database, 5Cell Signaling Technology, 30KEGG
See all sources

Pathways related to Multiple System Atrophy according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.6SNCA, SLC6A3
29.6SLC6A3, SNCA
39.4FMR1, SNCB, SNCA
4
Show member pathways
8.6SLC6A3, DRD2, CHAT

Compounds for genes affiliated with Multiple System Atrophy

About this section
Sources:
45Novoseek, 24HMDB, 11DrugBank, 29IUPHAR, 61Tocris Bioscience, 51PharmGKB, 3BitterDB
See all sources

Compounds related to Multiple System Atrophy according to GeneCards/GeneDecks:

(show top 50)    (show all 63)
idCompoundScoreTop Affiliating Genes
1thioflavine s4510.1SNCA, RPS27A
2methionine sulfoxide45 24 1112.1CRYAB, SNCA
31-benzyl-1,2,3,4-tetrahydroisoquinoline4510.1SNCA, SLC6A3
4acetyl-l-carnitine459.9FMR1, CHAT
5ibotenic acid459.8SLC6A3, CHAT
61 methyl 4 phenylpyridinium459.6SLC6A3, SNCA
7rotenone459.6SNCA, RPS27A, SLC6A3
84-hydroxynonenal45 2410.5RPS27A, SNCA, CHAT
9ibzm459.5SLC6A3, DRD2
10alpha-methyl-p-tyrosine459.5DRD2, SLC6A3
11tetrabenazine45 29 61 51 1113.5DRD2, SLC6A3
12d amphetamine459.5SLC6A3, DRD2
13dizocilpine459.5CHAT, DRD2
14raclopride45 2910.5DRD2, SLC6A3
15piperazine45 1110.4SLC6A3, DRD2
16trimipramine45 51 1111.4DRD2, SLC6A3
17choline45 24 1111.4CHAT, SNCA, SLC6A3
18methylphenidate45 51 1111.4DRD2, SLC6A3
19sulpiride45 29 1111.4DRD2, SLC6A3
20reserpine45 29 1111.4SLC6A3, DRD2
21valine459.3SLC6A3, RPS27A, SNCA
22maoa459.3DRD2, SLC6A3
23silver459.2FMR1, RPS27A, SNCA, CHAT
24amphetamine45 51 1111.2SLC6A3, DRD2, SNCA
25pirenzepine45 29 1111.2CHAT, DRD2
26phencyclidine45 29 1111.1SLC6A3, DRD2
27paraffin459.1CHAT, SNCA, RPS27A, CRYAB
28heroin45 51 1111.0SLC6A3, DRD2, CHAT
29pramipexole45 29 51 1112.0SLC6A3, DRD2
30risperidone45 51 29 61 24 1114.0SLC6A3, DRD2, CHAT
31olanzapine45 51 29 24 1113.0SLC6A3, DRD2, CHAT
32haloperidol45 51 29 3 1113.0SLC6A3, DRD2, CHAT
335-hydroxytryptamine458.9CHAT, DRD2, SLC6A3
34testosterone45 61 24 1111.9CHAT, SNCA, RPS27A, FMR1
35aspartate458.9SLC6A3, CRYAB, RPS27A, CHAT
36h2o2458.8SLC6A3, CRYAB, RPS27A, SNCB, SNCA
37quinpirole45 299.8SLC6A3, DRD2
38nicotine45 29 51 1111.8CHAT, DRD2, SLC6A3
39mptp458.8SLC6A3, DRD2, RPS27A, SNCA
40levodopa45 119.8SNCA, RPS27A, DRD2, SLC6A3
41apomorphine29 45 1110.7CHAT, SNCA, DRD2, SLC6A3
42cocaine45 119.7CHAT, SNCA, DRD2, SLC6A3
43nmda45 299.5CHAT, RPS27A, DRD2, SLC6A3
44methamphetamine45 51 1110.3SLC6A3, DRD2, RPS27A, SNCA, CHAT
456-hydroxydopamine458.3CHAT, SNCA, RPS27A, DRD2, SLC6A3
46acetylcholine45 51 29 24 1112.3CHAT, SNCA, RPS27A, DRD2, SLC6A3
47dopamine45 29 24 1111.3CHAT, SNCA, RPS27A, DRD2, SLC6A3
48gaba458.2CHAT, RPS27A, FMR1, DRD2, SLC6A3
49norepinephrine45 24 1110.1SLC6A3, DRD2, SQSTM1, SNCA, CHAT
50glutamate457.9CHAT, SNCA, RPS27A, FMR1, DRD2, SLC6A3

GO Terms for genes affiliated with Multiple System Atrophy

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Multiple System Atrophy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1terminal boutonGO:0431959.8SNCB, SNCA
2neuronal cell bodyGO:0430258.8SLC6A3, SNCB, CHAT
3mitochondrionGO:0057398.6CHAT, SNCA, SNCB, COQ2, CRYAB
4axonGO:0304248.4SLC6A3, DRD2, SNCA, CHAT
5cytoplasmGO:0057377.6NUB1, CHAT, SNCA, SNCB, FMR1, CRYAB

Biological processes related to Multiple System Atrophy according to GeneCards/GeneDecks:

(show all 23)
idNameGO IDScoreTop Affiliating Genes
1response to interferon-gammaGO:03434110.1SNCA, NUB1
2synapse organizationGO:05080810.0SNCB, SNCA
3dopamine biosynthetic processGO:04241610.0SNCA, SLC6A3
4negative regulation of cysteine-type endopeptidase activity involved in apoptotic processGO:0431549.7CRYAB, SNCA
5neurotransmitter biosynthetic processGO:0421369.7CHAT, SLC6A3
6stress-activated MAPK cascadeGO:0514039.7RPS27A, CRYAB
7behavioral response to cocaineGO:0481489.7SNCA, DRD2
8dopamine metabolic processGO:0424179.7SNCB, DRD2
9regulation of long-term neuronal synaptic plasticityGO:0481699.6DRD2, SNCA
10agingGO:0075689.6SLC6A3, CRYAB, SNCA
11adenohypophysis developmentGO:0219849.5SLC6A3, DRD2
12response to iron ionGO:0100399.4DRD2, SLC6A3
13prepulse inhibitionGO:0601349.4SLC6A3, DRD2
14response to cocaineGO:0422209.4DRD2, SLC6A3
15response to nicotineGO:0350949.4SLC6A3, DRD2
16positive regulation of multicellular organism growthGO:0400189.3SLC6A3, DRD2
17adult walking behaviorGO:0076289.3CHAT, DRD2
18endosomal transportGO:0161979.3RPS27A, SQSTM1
19sensory perception of smellGO:0076089.1SLC6A3, DRD2
20protein localizationGO:0081049.1SQSTM1, DRD2
21negative regulation of apoptotic processGO:0430669.0CRYAB, SQSTM1, RPS27A, SNCA
22response to drugGO:0424939.0SLC6A3, DRD2, SNCA
23synaptic transmissionGO:0072688.8SLC6A3, SNCB, CHAT

Molecular functions related to Multiple System Atrophy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1beta-tubulin bindingGO:0484879.8SNCB, SNCA
2alpha-tubulin bindingGO:0430149.5SNCB, SNCA
3dopamine bindingGO:0352409.1SLC6A3, DRD2
4identical protein bindingGO:0428028.2SNCA, SQSTM1, CRYAB, DRD2

Products for genes affiliated with Multiple System Atrophy

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Multiple System Atrophy

About this section
4CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
52PubMed
53QIAGEN
59SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet